Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Pharmacoepidemiology and Drug Safety|May 5, 2026
Beta Blocker Use and Total Knee Arthroplasty Among United States Medicare BeneficiariesShailina Keshwani, Haesuk Park, Wei-Hsuan Lo-Ciganic, et al.JAMA Network Open|June 11, 2021
Trends in Use of Prescription Nonsteroidal Anti-inflammatory Medications Before vs After Implementation of a Florida Law Restricting Opioid Prescribing for Acute PainShailina Keshwani, Ivanna Grande, Michael Maguire, et al.Journal of the American Geriatrics Society|March 15, 2026
Association Between Different Analgesic Use and Hypertension Among Medicare Beneficiaries With OsteoarthritisShailina Keshwani, Haesuk Park, Wei-Hsuan Lo-Ciganic, et al.JAMA Health Forum|August 17, 2022
Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid ProgramsShailina Keshwani, Michael Maguire, Amie Goodin, et al.Pharmacotherapy|September 29, 2023
Modifiable statin characteristics associated with potential statin-related prescribing cascadesGrace Hsin-Min Wang, Earl Morris, Scott M Vouri, et al.The Journal of Pain|June 17, 2023
Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting From 2006 to 2016Shailina Keshwani, Steven M Smith, Joshua Brown, et al.Journal of the American Heart Association|December 24, 2022
Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research NetworkSteven M Smith, Almut G Winterstein, Matthew J Gurka, et al.American Journal of Hypertension|April 22, 2025
Disparities in Initial Antihypertensive Intensity by Sex, Race and Ethnicity in Newly-Treated Patients with HypertensionShailina Keshwani, Kayla M Smith, Almut G Winterstein, et al.Pharmacotherapy|October 21, 2025
High-Throughput Screening for Prescribing Cascades Among Real-World Angiotensin-II Receptor Blockers (ARBs) InitiatorsAsinamai M Ndai, Kayla Smith, Shailina Keshwani, et al.Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
High-Throughput Screening for Prescribing Cascades Among Real-World Angiotensin-II Receptor Blockers (ARBs) InitiatorsAsinamai M Ndai, Kayla Smith, Shailina Keshwani, et al.Pageof 2